Navigation Links
Kendle Announces Departure of Senior Vice President and CFO Karl 'Buzz' Brenkert III; Appoints Keith A. Cheesman as Successor

CINCINNATI, April 28 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Karl "Buzz" Brenkert III, Senior Vice President, Chief Financial Officer (CFO) and Secretary, will depart the Company effective May 6, 2009. Brenkert has served as CFO of the Company since January 2003. Succeeding Brenkert as Senior Vice President and CFO is Keith A. Cheesman, Vice President, Accounting and a current member of Kendle's Finance senior management team. As CFO Cheesman will oversee the Company's global financial operations, including Finance, Accounting, Budgeting, Tax, Investor Relations and Financial Planning.

(Logo: )

"We extend our appreciation to Buzz for his service to Kendle and wish him well," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. She continued, "We are pleased to appoint Keith as CFO and look forward to his expanded role as part of our executive team."

Cheesman brings 28 years of experience in corporate finance and accounting management to the CFO role, including previous experience as Vice President, Finance; Chief Financial Officer; and Treasurer for a publicly traded site management organization. Cheesman has served as a member of Kendle's Finance senior management team from 2000 to 2004 and from January 2008 to present and has provided leadership for nearly all facets of the Company's financial operations. From 2004 to 2008 he broadened his experience by serving as Vice President - Corporate Controller and a member of the senior management team for Ohio Casualty Corporation, a publicly traded U.S. property and casualty insurance provider with $1.5 billion in annual premiums and 2,100 employees across 20 U.S. locations. Cheesman rejoined Kendle in January 2008, assuming expanded leadership responsibilities as Vice President, Accounting responsible for the Company's Accounting, Tax, Project Financial Support and Internal Audit functions.

Cheesman holds a Bachelor of Science in accounting from University of Dayton. He is a member of the American Institute of Certified Public Accountants, Ohio Society of Certified Public Accountants and Financial Executives International.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Host Conference Call to Discuss Revised 2009 Outlook
2. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
3. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2008 Earnings and 2009 Guidance Release, Webcast and Conference Call
5. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference
6. Kendle to Present at the 2008 Credit Suisse Health Care Conference
7. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
8. Kendle Named a Best Place to Work in Greater Cincinnati
9. Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations
10. Kendle Named to FORTUNE List of 100 Fastest-Growing Companies for 2008
11. Kendle to Present at the UBS Global Life Sciences Conference
Post Your Comments:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... their findings on what they believe could be a new and helpful biomarker ... new research. Click here to read it now. , Biomarkers are ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
Breaking Biology Technology:
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):